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Background: Electrolyte values are measured in most critically ill intensive care unit (ICU) patients using both an
arterial blood gas analyzer (ABG) and a central laboratory auto-analyzer (AA). The aim of the present study was to
investigate whether electrolyte levels assessed using an ABG and an AA were equivalent; data on sodium and
potassium ion concentrations were examined.
Methods: We retrospectively studied patients hospitalized in the ICU between July and August 2011. Of 1,105 test
samples, we identified 84 instances of simultaneous sampling of arterial and venous blood, where both Na+ and K+
levels were measured using a pHOx Stat Profile Plus L blood gas analyzer (Nova Biomedical, Waltham MA, USA) and
a Roche Modular P autoanalyzer (Roche Diagnostics, Mannheim, Germany). Statistical measures employed to
compare the data included Spearman's correlation coefficients, paired Student’s t-tests, Deming regression analysis,
and Bland-Altman plots.
Results: The mean sodium concentration was 138.1 mmol/L (SD 10.2 mmol/L) using the ABG and 143.0 mmol/L
(SD 10.5) using the AA (p < 0.001). The mean potassium level was 3.5 mmol/L (SD 0.9 mmol/L) using the ABG and
3.7 mmol/L (SD 1.0 mmol/L) using the AA (p < 0.001). The extent of inter-analyzer agreement was unacceptable for
both K+ and Na+, with biases of 0.150-0.352 and −0.97-10.05 respectively; the associated correlation coefficients
were 0.88 and 0.90.
Conclusions: We conclude that the ABG and AA do not yield equivalent Na+ and K+ data. Concordance between
ABG and AA should be established prior to introduction of new ABG systems.Background
Electrolytes are charged elements that are essential for
proper cellular functioning in most tissues of the body.
Almost all metabolic processes are dependent upon or
are mediated by electrolytes. Variation in electrolyte
concentrations may be either the cause or the conse-
quence of a variety of disorders; such problems must be
identified to ensure adequate treatment. Electrolyte ab-
normalities can represent significant risks to life [1].
In the intensive care unit (ICU), electrolyte values are
measured in most critically ill patients [2]. Under such
circumstances it is important to obtain data quickly so* Correspondence: yaseminbudak2000@yahoo.com
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reproduction in any medium, provided the oras to optimize the therapeutic response interval and
allow prompt treatment.
Two methods of electrolyte assay, one direct and one
indirect, both employing ion-sensing electrodes (ISEs),
are currently in use in most hospitals [3]. The indirect
assay features pre-analytic dilution and is often
employed in high-throughput central hospital laborator-
ies running automated analyzers (AAs) [3]. In the direct
ISE method, the electrode surface contacts a complete
undiluted blood sample; this approach is employed by
arterial blood gas analyzers (ABGs) or point-of-care test-
ing (POCT) equipment [3]. Indirect ISE devices use
diluted plasma (or serum) samples; the results are gener-
ally comparable to those afforded by flame photometry
(the recognized reference method) [4]. Sodium and po-
tassium levels measured in whole blood and plasma have
been shown to be essentially identical [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The between-run precision of electrolyte assay
data were determined via analysis of duplicate quality
control materials on each of 20 days
Electrolyte
(mmol/L)
AA %CV ABG %CV
Mean Mean
Sodium 140.3 1.36 157.0 1.36
115.7 2.12 133.6 2.12
Potassium 6.03 1.67 5.60 1.67
3.47 2.76 3.79 2.76
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cause a long delay between the time at which a test is
ordered and the time at which the result is received by a
clinician; such delays may compromise the treatment of
critically ill patients [6]. If analysis is performed in the
ICU several processing steps can be eliminated, results
are obtained rapidly, patient management is timely, and
outcomes improve. Of course, such advantages are pos-
sible only if the analytical performance of ICU-based
tests is acceptable in comparison with those of central
laboratory methods, and if the desired clinical criteria
are met [7].
ABG use is rising, particularly in ICUs, emergency
departments, and operating theatres; physicians fre-
quently rely on ABG test data but send an additional
sample to the central laboratory. The apparently tandem
use of ABG and central laboratory analyzers to measure
electrolytes increases the variability of test results; the
reliability and validity of such data require examination.
In the present study we explored whether sodium and
potassium ion concentrations measured with an ABG
and an AA were equivalent.
Methods
We conducted a retrospective study on data contained
in the Şevket Yilmaz Research and Education Hospital
Clinical Data Warehouse, a centralized data repository
integrating information in several databases including
the order entry database and the laboratory results data-
base of our hospital. Prescription data are linked to
detailed clinical information including patient demo-
graphics, diagnosis, and laboratory data; the latter in-
clude specimen collection date, time, and location
(for example: ICU).
Study population
The present study was approved by the Ethics Commit-
tee of the Bursa Sevket Yilmaz Research and Educational
Hospital. All procedures were in accordance with the
Second Declaration of Helsinki.
We studied patients who had been hospitalized in the
ICU for some time in the interval between July and
August 2011. We identified 84 instances, of 1,105 pa-
tient blood gas samples analyzed, in which arterial and
venous samples were collected simultaneously and Na+
and K+ were measured using two methods. In the ICU,
arterial blood samples were collected in heparinized
blood–gas syringes (Gaslyte, Totawa, NJ) and analyzed
using a benchtop blood–gas analyzer (pHOx Stat Profile
Plus L, Nova Biomedical, Waltham MA, USA) which
employs direct ISE technology. The blood gas analyzer
was calibrated with the aid of a Nova Biomedical calibra-
tor pack provided by the supplier, in line with NIST
standards.We identified patients from whom a further sample
was drawn, at the same time, from the same arterial
sampling point, using a vacuum technique featuring
clot-activating tubes (Green-Vac, Yongin, Korea); the
samples were sent, pneumatically sealed, to our central
laboratory, where serum Na+ and K+ concentrations
were analyzed via indirect ISE on a Roche Modular ISE
900 (Roche Diagnostics, Mannheim, Germany).
Analytical precision of Na+ and K+ determinations
Before data analysis, we ran a two-level quality-control
(QC) test using materials supplied by the manufacturers
of both devices (Stat Profile pHOx Plus Control 1, 2;
Lots 011004 and 011005, and PreciControl ClinChem
Multi 1; Lots 158565 and 158577). The reproducibility
of results obtained throughout the study was evaluated
via analysis of duplicate QC samples on each of 20 days
(between-day differences were calculated) (Table 1). For
quality assurance purposes, our laboratory participates
in the Riqas external quality assessment scheme; Cycle 8
(Samples 7–8) ran during the study interval. The mean
comparative K+ level (instrument group mean) was
4.195 mmol/l whereas our figure was 4.2 mmol/l; the
mean K+ level was 6.04 mmol/l whereas our figure was
6.35 mmol/l; the mean Na+ level was 143.71 mmol/l
whereas our figure was 144.0 mmol/l; and the mean
comparative Na+ level (instrument group mean) was
157.18 mmol/l whereas our figure was 155 mmol/l.
Statistical methods
Data were evaluated using SPSS version 13.0 (SPSS Inc.,
Chicago, IL) and Analyse-It version 2.04 (Analyse-It
Software, Leeds, UK). Data were tested for normality
using the Kolmogorov-Smirnov test. Means, standard
deviations, and coefficients of variation were calculated.
Deming regression analysis was performed and Bland–
Altman plots were constructed to compare the results of
the two methods [8]. p < 0.001 was considered statisti-
cally significant.
Results
The mean sodium level measured on the ABG was
138.1 mmol/L (SD 10.2 mmol/L) and the value obtained
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significant difference was evident when the mean (±SD)
sodium levels yielded by the ABG and AA were com-
pared (p < 0.001). The maximum difference in sodium
level was 12 mmol/L and the minimum 0 mmol/L. The
mean difference was 4.9 mmol/L with an SD of
3.0 mmol/L (p < 0.001). As a significant difference was
detected, the null hypothesis was rejected. The correl-
ation coefficient (the r2 value) was 0.90. The adjusted r2
value was associated with a 95% confidence interval of
0.90-0.94.
A Bland–Altman comparison of central laboratory AA
data with ICU ABG Na+ measurements showed that the
limits of agreement were minus 0.97 to 10.05 mmol/L
(Figure 1).
Deming regression analysis of the ABG and AA data
on Na+ levels yielded the following formula: [ABG Na+
(mmol/L) = 3.41 + 0.94 AA Na+ (mmol/L)] (Figure 2).
Analysis of the potassium levels measured using the
ABG and the AA yielded a mean difference of
0.25 mmol/L with a SD of 0.43 mmol/L. A significant
difference was evident (p < 0.001; the null hypothesis
was thus rejected) between K+ levels measured by
the ABG (3.5 mmol/L, SD 0.9 mmol/L) and the
AA (mean 3.7 mmol/L, SD 1.0 mmol/L). The max-
imum difference in measured potassium value was
1.96 mmol/L, and the minimum 0 mmol/L (Figure 3).
The correlation coefficient (the r2 value) was 0.88. The
adjusted r2 value was associated with a 95% confidence
interval of 0.81-0.92. Deming regression analysis of
the ABG and AA data on K+ levels yielded the follow-






























Figure 1 Bland-Altman plot of AA and ABG blood Na+ showing the 9Bland–Altman comparison of the AA and ABG K+
data yielded limits of agreement of 0.150 and
0.352 mmol/L.
Discussion
In the present study we investigated whether Na+ and
K+ levels measured using different methods and equip-
ment, namely an ABG and an AA, were equivalent. If so,
the data could be employed interchangeably in routine
practice.
To ensure the accuracy of test results, our central la-
boratory (employing an AA) participates in an external
quality assessment (EQA) program; both electrolytes
were assayed with reasonable accuracy during the study
period. However, the accuracy of ABG data was not eval-
uated via any EQA program; this is an important limita-
tion of the present study.
The between-day imprecision of both instruments
(AA and ABG) was small and lacked clinical significance
when compared with analytical performance indicators
based on biological variation [9] or with the United
States Clinical Laboratory Improvement Amendments
(US CLIA) 88 performance rules [10].
Data from the ABG appeared to be correlated with
AA results (r2 = 0.88 for K+ and 0.90 for Na+); the
strength of the relationships between the two variables
was acceptable.
However, biological variations in electrolyte levels are
so small that a slight error will cause patients to be mis-
diagnosed [9]. The US CLIA 1988 rules accept a differ-
ence of 0.5 mmol/L in potassium level, and 4 mmol/L in
sodium level, compared to target values [10]. In our






5% limits of agreement.
Figure 2 Deming fit (solid black line) with 95% confidence intervals for the ABG Na results vs laboratory (AA) Na results.
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value of 4 mmol/L and the 95% limits of agreement of
the difference were minus 0.97 and 10.05 mmol/L.
Our data are in line with those of previous studies [11-



























Figure 3 Bland-Altman plot of AA and ABG blood K+ showing the 95types of measurement differ significantly, and to an ex-
tent that may affect therapeutic choice. Our patients
were critically ill in the intensive care unit (ICU). Chow
et al. [14] reported that direct ISE sodium and potassium






























Figure 4 Deming fit (solid black line) with 95% confidence intervals for the ABG K+ results vs laboratory (AA) K + results.
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characteristic of critically ill patients. In such patients,
direct ISE offers more accurate and consistent electro-
lyte results than does indirect ISE.
The mean between-assay difference in K+ levels was
0.25 mmol/L. Although the mean difference between the
results of the two K+ assays was within the range given
by the US CLIA 1988 guidelines [10], a difference of
0.25 mmol/l is clinically relevant when intra-individual
variation is considered. When it is recalled that the
intra-individual biological variation in K+ level has been
reported to be 4.8% [15], any bias exhibited by either
method did not exceed the acceptable level of inaccuracy
[15]. It is important to emphasize that the cited criteria
are very strict; the acceptable inaccuracy in terms of po-
tassium measurement is only 1.8% [15]. It is likely that
the observed variations in K+ values of paired samples
are attributable to differences in sample type, thus serum
or whole blood. It is well known that potassium is
released from platelets during clotting [16] and it is thus
not surprising that serum potassium values are higher
than are whole-blood levels. The magnitude of the dif-
ference observed by us was similar to that earlier
reported (0.1-0.7 mmol/L) [3]. After obtaining analytical
results similar to ours, Jain et al. [11] suggested that it
was safe to make clinical decisions based on serum K+levels yielded by an ABG instrument. However, in 15%
of our patients the errors were greater than 0.5 mmol/L;
this may have implications in clinical practice.
Although the differences in electrolyte levels obtained
using the two methods are sufficiently small to not raise
a risk of inappropriate therapy in most instances,
Morimatsu et al. [12] calculated the anion gap and the
strong ion difference in critically ill patients using results
obtained from a central laboratory analyzer and a POCT
device; the Stewart-Figge formula was employed. The
cited authors showed that the values calculated using
data obtained by different methods differed significantly;
clinical interpretation and consequent therapeutic
decision-making could be adversely affected.
The observed differences between electrolyte levels
measured using an ABG and an AA may be explained
by a combination of factors, including sample transport,
dilution of serum samples prior to testing (thus, the use
of indirect vs. direct electrodes), and variations in instru-
ment calibration [16,17]. It is known that ISE-based
instruments from different manufacturers yield Na+/K+
values that differ by 2–5%; calibration of an AA using a
NIST standard lowers the figures [18]. Also, it has re-
cently been reported that the use of different types of
heparin in blood gas syringes can introduce a pre-
analytical bias in electrolyte concentrations. Such
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the levels of positively charged ions are measured. The
extent of bias differs among syringe types [19,20].
The wide intratest variability, as shown in the Bland-
Altman plots, and the statistically significant mean dif-
ferences in measured ion levels between the two meth-
ods, suggest that the tests do not yield equivalent data.
It is possible to compensate for variation caused by
known factors using a correction factor, to render data
from different instruments comparable. The question is
whether such compensation is appropriate. Although a
correction factor featuring compensation based on varia-
tions in average values can minimize differences between
the data from two analyzers in some instances [21], we
cannot recommend this approach toward comparison of
Na+ and K+ test results.
Our present study illustrates the importance of deter-
mining the concordance, for each individual hospital, of
electrolyte values obtained by ABG and those obtained
in the central laboratory. As instrument type and cali-
bration methods may differ among hospitals, it is im-
portant that each center conducts an in-house study.
Ideally, before installation of an ABG, it would be useful
to carefully evaluate the clinical significance of any dif-
ference between data yielded by central laboratory
devices and POCT instruments. Such an evaluation
should be conducted prior to ABG installation; this was
unfortunately not the case in our hospital. Individual la-
boratories should utilize external NIST Standard SRM
956 to verify calibrations conducted by manufacturers
and to ensure that the results afforded by direct and in-
direct ISEs (18) do not differ to a clinically relevant
extent.
A limitation of our work is that, in the absence of clin-
ical review, we were unable to identify any dataset as
containing erroneous values. It was not possible to es-
tablish whether the central laboratory or ABG values
were closer to the true values for either analyte.
Conclusions
Na+ and K+ test results obtained using an ABG and an
AA differ and the data thus cannot be used interchange-
ably in clinical practice. Physicians need to be aware of
between-assay differences to avoid potential misdiag-
nosis and initiation of unnecessary treatment or
investigation.
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